HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit
NEW YORK, Jan. 3, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Humacyte, Inc. (NASDAQ: HUMA) between May 10, 2024 and


